Year Wise Statistics
Total Downloads
283,462
Fulltext
193,254
PDF
90,208
283,462
Fulltext
193,254
90,208
Articles | Fulltext downloads | PDF downloads | Total downloads |
---|---|---|---|
Short CommunicationDriver mutations in oncogenesisFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020 |
8,866 | 1,452 | 10,318 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_5_2023 |
6,639 | 473 | 7,112 |
Review ArticleArtificial intelligence in radiation oncology: How far have we reached?Full text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_32_2022 |
5,248 | 1,305 | 6,553 |
Review ArticleCombination of PARPi and anti-PD-L1 therapies in ovarian cancerFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022 |
5,941 | 252 | 6,193 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022 |
5,936 | 242 | 6,178 |
Case ReportCHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathwayFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_25_2022 |
5,192 | 942 | 6,134 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023 |
5,643 | 404 | 6,047 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022 |
5,003 | 355 | 5,358 |
Molecular Insight StorySystemic mastocytosis with an associated hematological neoplasm (acute myeloid leukaemia with RUNX1::RUNX1T1 fusion) – A case studyFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2023 |
4,280 | 1,058 | 5,338 |
Original ArticleRole of fiberoptic bronchoscopy-guided needle aspiration cytology (EBNA) in diagnosing lung cancer in endobronchial lesions: A single-center experienceFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_31_2022 |
4,480 | 799 | 5,279 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text![]() ![]() ![]() Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020 |
2,708 | 2,333 | 5,041 |
EditorialEditorialFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_23_2022 |
4,583 | 432 | 5,015 |
EditorialBench to clinic – Molecular oncology fast tracking curesFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2023 |
3,691 | 1,158 | 4,849 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023 |
4,394 | 231 | 4,625 |
Review ArticleMyeloid neoplasms on poly (ADP-ribose) polymerase inhibitor therapyFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2022 |
3,428 | 1,005 | 4,433 |
Review ArticleHER2 ‘neu’ promise for mCRCFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2022 |
3,353 | 1,079 | 4,432 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023 |
4,223 | 110 | 4,333 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023 |
4,028 | 151 | 4,179 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023 |
4,049 | 127 | 4,176 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023 |
4,015 | 139 | 4,154 |
Original ArticleThe effects of expressive writing intervention in cancer patients and survivors: A rapid umbrella reviewFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_24_2022 |
3,188 | 836 | 4,024 |
NewsEditorial board tribute to Dr. Amit VermaFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 3, September-December |
2,502 | 1,211 | 3,713 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
2,816 | 613 | 3,429 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022 |
1,853 | 1,520 | 3,373 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022 |
1,874 | 1,496 | 3,370 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022 |
1,709 | 1,485 | 3,194 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text![]() ![]() ![]() Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019 |
2,153 | 1,018 | 3,171 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020 |
1,860 | 1,240 | 3,100 |
Letter to EditorLetter to editorFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022 |
1,927 | 998 | 2,925 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text![]() ![]() ![]() Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019 |
2,261 | 658 | 2,919 |
Review ArticleMolecular targets in urinary bladder cancerFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_4_2022 |
2,018 | 863 | 2,881 |
Case ReportTargeted therapy with trametinib in infantile refractory langerhans cell histiocytosis: A case reportFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_4_2023 |
2,406 | 444 | 2,850 |
Case ReportA FANCA mutation carrier with enhanced toxicity to cancer directed treatment – A case report and review of literatureFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_1_2023 |
2,396 | 443 | 2,839 |
Review ArticleImmuno-oncological era of breast cancer: A progressive path to better treatmentFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022 |
824 | 1,933 | 2,757 |
Case ReportMetastatic endometrial carcinoma responsive to pembrolizumabFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020 |
807 | 1,884 | 2,691 |
Review ArticleCell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biologyFull text![]() ![]() ![]() Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019 |
921 | 1,734 | 2,655 |
Review ArticleResistance to poly ADP-ribose polymerase inhibitors and its clinical implicationsFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022 |
1,300 | 1,222 | 2,522 |
Case ReportA rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lungFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2022 |
1,526 | 970 | 2,496 |
EditorialTrends of germline mutations in women with breast and ovarian carcinomaFull text![]() ![]() ![]() Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_7_2023 |
2,151 | 305 | 2,456 |
Case ReportRedefining the treatment of metastatic uveal melanoma with immunotherapy – A case reportFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022 |
1,333 | 1,103 | 2,436 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022 |
1,426 | 970 | 2,396 |
Case SeriesDual driver in non-small cell lung carcinoma – therapeutic dilemmaFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021 |
1,175 | 1,154 | 2,329 |
Review ArticleSevere acute respiratory syndrome coronavirus 2: Mutations and variants of concern – the Indian scenarioFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_14_2021 |
1,275 | 1,028 | 2,303 |
Review ArticleImpact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic reviewFull text![]() ![]() ![]() Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019 |
1,116 | 1,177 | 2,293 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text![]() ![]() ![]() Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019 |
1,379 | 911 | 2,290 |
Review ArticleClinical application of molecular genetics in acute myeloid leukemiaFull text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_22_2022 |
1,844 | 419 | 2,263 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text![]() ![]() ![]() Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022 |
1,084 | 950 | 2,034 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021 |
817 | 1,216 | 2,033 |
Review ArticleMolecular genetic changes in gastric carcinomaFull text![]() ![]() ![]() Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_8_2020 |
1,598 | 331 | 1,929 |
Original ArticleReal World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in IndiaFull text![]() ![]() ![]() Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019 |
685 | 1,216 | 1,901 |